Altered glycolysis and mitochondrial respiration in a zebrafish model of Dravet syndrome

eNeuro

Volumn 3, Issue 2, 2016, Pages 1002-1011

  Kumar, Maneesh G ^a   Rowley, Shane ^a   Fulton, Ruth ^a   Dinday, Matthew T ^b   Baraban, Scott C ^b   Patel, Manisha ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; FAMPRIDINE; HISTOCOMPATIBILITY ANTIGEN; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.1;

ARTICLE; BIOENERGY; CITRIC ACID CYCLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE DOSAGE; GENE EXPRESSION; GLUCOSE METABOLISM; GLYCOLYSIS; LARVA; MITOCHONDRIAL RESPIRATION; NERVE EXCITABILITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY CHAIN; SEVERE MYOCLONIC EPILEPSY IN INFANCY; ZEBRA FISH; ANIMAL; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KETOGENIC DIET; METABOLISM; MITOCHONDRION; MUTATION; MYOCLONUS EPILEPSY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROCEDURES; TRANSGENIC ANIMAL;

4-AMINOPYRIDINE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CITRIC ACID CYCLE; DISEASE MODELS, ANIMAL; EPILEPSIES, MYOCLONIC; GENE EXPRESSION REGULATION; GLYCOLYSIS; HISTOCOMPATIBILITY ANTIGENS; KETOGENIC DIET; LARVA; MITOCHONDRIA; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; OXYGEN CONSUMPTION; POTASSIUM CHANNEL BLOCKERS; STATISTICS, NONPARAMETRIC; ZEBRAFISH;

EID: 85002714982     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0008-16.2016     Document Type: Article

References (34)

1. Artuso L, Romano A, Verri T, Domenichini A, Argenton F, Santorelli FM, Petruzzella V (2012) Mitochondrial DNA metabolism in early development of zebrafish (Danio rerio). Biochim Biophys Acta 1817: 1002-1011. CrossRef Medline
2. Baraban SC, Taylor MR, Castro PA, Baier H (2005) Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-Fos expression. Neuroscience 131: 759-768. CrossRef
3. Baraban SC, Dinday MT, Hortopan GA (2013) Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat Commun 4: 2410. CrossRef Medline
4. Baraban SC, Dinday MT, Castro PA, Chege S, Guyenet S, Taylor MR (2007) A large-scale mutagenesis screen to identify seizureresistant zebrafish. Epilepsia 48: 1151-1157. CrossRef Medline
5. Caraballo RH (2011) Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia 52: 79-82. CrossRef Medline
6. Chugani HT, Rintahaka PJ, Shewmon DA (1994) Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia 35: 813-822. Medline
7. Craig AK, de Menezes MS, Saneto RP (2012) Dravet syndrome: patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects. Seizure 21: 17-20. CrossRef
8. Dinday MT, Baraban SC (2015) Large-scale phenotype-based antiepileptic drug screening in a zebrafish model of Dravet syndrome(1,2,3). eNeuro 2: ENEURO.0068-15.2015. CrossRef Medline
9. Dravet C (2011) The core Dravet syndrome phenotype. Epilepsia 52: 3-9. CrossRef Medline
10. Finsterer J, Zarrouk Mahjoub S (2012) Epilepsy in mitochondrial disorders. Seizure 21: 316-321. CrossRef Medline
11. Flynn JM, Choi SW, Day NU, Gerencser AA, Hubbard A, Melov S (2011) Impaired spare respiratory capacity in cortical synaptosomes from Sod2 null mice. Free Radic Biol Med 50: 866-873. CrossRef Medline
12. Gano LB, Patel M, Rho JM (2014) Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res 55: 2211-2228. CrossRef Medline
13. Giménez-Cassina A, Martinez-François JR, Fisher JK, Szlyk B, Polak K, Wiwczar J, Tanner GR, Lutas A, Yellen G, Danial NN (2012) BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 74: 719-730. CrossRef
14. Grisar T (1984) Glial and neuronal Na+-K+ pump in epilepsy. Ann Neurol 16: S128-S134. Medline
15. Hunter SE, Jung D, Di Giulio RT, Meyer JN (2010) The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number. Methods 51: 444-451. CrossRef Medline
16. Jornayvaz FR, Jurczak MJ, Lee HY, Birkenfeld AL, Frederick DW, Zhang D, Zhang XM, Samuel VT, Shulman GI (2010) A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am J Physiol Endocrinol Metab 299: E808-E815. CrossRef Medline
17. Kunz WS, Kudin AP, Vielhaber S, Blümcke I, Zuschratter W, Schramm J, Beck H, Elger CE (2000) Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 48: 766-773. Medline
18. Lee EM, Park GY, Im KC, Kim ST, Woo CW, Chung JH, Kim KS, Kim JS, Shon YM, Kim YI, Kang JK (2012) Changes in glucose metabolism and metabolites during the epileptogenic process in the lithium-pilocarpine model of epilepsy. Epilepsia 53: 860-869. CrossRef Medline
19. Liang LP, Waldbaum S, Rowley S, Huang TT, Day BJ, Patel M (2012) Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin. Neurobiol Dis 45: 1068-1076. CrossRef Medline
20. Ma W, Berg J, Yellen G (2007) Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J Neurosci 27: 3618-3625. CrossRef Medline
21. Ma YY, Zhang XL, Wu TF, Liu YP, Wang Q, Zhang Y, Song JQ, Wang YJ, Yang YL (2011) Analysis of the mitochondrial complex I-V enzyme activities of peripheral leukocytes in oxidative phosphorylation disorders. J Child Neurol 26: 974-979. CrossRef Medline
22. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 34: 609-616. CrossRef Medline
23. Murata Y, Nishio K, Mochiyama T, Konishi M, Shimada M, Ohta H, Itoh N (2013) Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet. PloS One 8: e69330. CrossRef Medline
24. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO (1996) Requirement for superoxide in excitotoxic cell death. Neuron 16: 345-355. Medline
25. Rowley S, Liang LP, Fulton R, Shimizu T, Day B, Patel M (2015) Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy. Neurobiol Dis 75: 151-158. CrossRef Medline
26. Ryan K, Backos DS, Reigan P, Patel M (2012) Post-translational oxidative modification and inactivation of mitochondrial complex I in epileptogenesis. J Neurosci 32: 11250-11258. CrossRef Medline
27. Stackley KD, Beeson CC, Rahn JJ, Chan SS (2011) Bioenergetic profiling of zebrafish embryonic development. PloS One 6: e25652. CrossRef Medline
28. Stafstrom CE, Roopra A, Sutula TP (2008) Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG). Epilepsia 49: 97-100. CrossRef Medline
29. Sun W, Chang SS, Fu Y, Liu Y, Califano JA (2011) Chronic CSE treatment induces the growth of normal oral keratinocytes via PDK2 upregulation, increased glycolysis and HIF1α stabilization. PloS One 6: e16207. CrossRef Medline
30. Taylor MR, Hurley JB, Van Epps HA, Brockerhoff SE (2004) A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet. Proc Natl Acad Sci U S A 101: 4584-4589. CrossRef Medline
31. Tenney JR, Rozhkov L, Horn P, Miles L, Miles MV (2014) Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia. Epilepsia 55: 1415-1422. CrossRef Medline
32. Tibbs GR, Barrie AP, Van Mieghem FJ, McMahon HT, Nicholls DG (1989) Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 53: 1693-1699. Medline
33. Wallace DC, Zheng XX, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM, Hopkins LC (1988) Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55: 601-610. Medline
34. Wu M (2009) Real-time measurement of mitochondrial respiration and glycolysis rates of cancer cells in a microplate AACR Education Book 2009 pp. 295-300.